Literature DB >> 22723521

Cross-species transcriptional network analysis defines shared inflammatory responses in murine and human lupus nephritis.

Celine C Berthier1, Ramalingam Bethunaickan, Tania Gonzalez-Rivera, Viji Nair, Meera Ramanujam, Weijia Zhang, Erwin P Bottinger, Stephan Segerer, Maja Lindenmeyer, Clemens D Cohen, Anne Davidson, Matthias Kretzler.   

Abstract

Lupus nephritis (LN) is a serious manifestation of systemic lupus erythematosus. Therapeutic studies in mouse LN models do not always predict outcomes of human therapeutic trials, raising concerns about the human relevance of these preclinical models. In this study, we used an unbiased transcriptional network approach to define, in molecular terms, similarities and differences among three lupus models and human LN. Genome-wide gene-expression networks were generated using natural language processing and automated promoter analysis and compared across species via suboptimal graph matching. The three murine models and human LN share both common and unique features. The 20 commonly shared network nodes reflect the key pathologic processes of immune cell infiltration/activation, endothelial cell activation/injury, and tissue remodeling/fibrosis, with macrophage/dendritic cell activation as a dominant cross-species shared transcriptional pathway. The unique nodes reflect differences in numbers and types of infiltrating cells and degree of remodeling among the three mouse strains. To define mononuclear phagocyte-derived pathways in human LN, gene sets activated in isolated NZB/W renal mononuclear cells were compared with human LN kidney profiles. A tissue compartment-specific macrophage-activation pattern was seen, with NF-κB1 and PPARγ as major regulatory nodes in the tubulointerstitial and glomerular networks, respectively. Our study defines which pathologic processes in murine models of LN recapitulate the key transcriptional processes active in human LN and suggests that there are functional differences between mononuclear phagocytes infiltrating different renal microenvironments.

Entities:  

Mesh:

Year:  2012        PMID: 22723521      PMCID: PMC3392438          DOI: 10.4049/jimmunol.1103031

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  61 in total

1.  Distinct macrophage phenotypes contribute to kidney injury and repair.

Authors:  Sik Lee; Sarah Huen; Hitoshi Nishio; Saori Nishio; Heung Kyu Lee; Bum-Soon Choi; Christiana Ruhrberg; Lloyd G Cantley
Journal:  J Am Soc Nephrol       Date:  2011-02       Impact factor: 10.121

2.  Integration of biological networks and gene expression data using Cytoscape.

Authors:  Melissa S Cline; Michael Smoot; Ethan Cerami; Allan Kuchinsky; Nerius Landys; Chris Workman; Rowan Christmas; Iliana Avila-Campilo; Michael Creech; Benjamin Gross; Kristina Hanspers; Ruth Isserlin; Ryan Kelley; Sarah Killcoyne; Samad Lotia; Steven Maere; John Morris; Keiichiro Ono; Vuk Pavlovic; Alexander R Pico; Aditya Vailaya; Peng-Liang Wang; Annette Adler; Bruce R Conklin; Leroy Hood; Martin Kuiper; Chris Sander; Ilya Schmulevich; Benno Schwikowski; Guy J Warner; Trey Ideker; Gary D Bader
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

Review 3.  Macrophages and immunologic inflammation of the kidney.

Authors:  Jeremy S Duffield
Journal:  Semin Nephrol       Date:  2010-05       Impact factor: 5.299

4.  Long-term prognosis and causes of death in systemic lupus erythematosus.

Authors:  Andrea Doria; Luca Iaccarino; Anna Ghirardello; Sandra Zampieri; Silvia Arienti; Piercarlo Sarzi-Puttini; Fabiola Atzeni; Antonio Piccoli; Silvano Todesco
Journal:  Am J Med       Date:  2006-08       Impact factor: 4.965

Review 5.  Experimental models of lupus nephritis.

Authors:  Joseph P Grande
Journal:  Contrib Nephrol       Date:  2011-01-20       Impact factor: 1.580

6.  Emerging Concepts in the Analysis of Transcriptional Targets of the MYC Oncoprotein: Are the Targets Targetable?

Authors:  Chi Van Dang; Steven B McMahon
Journal:  Genes Cancer       Date:  2010-06

7.  Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy.

Authors:  Maja T Lindenmeyer; Matthias Kretzler; Anissa Boucherot; Silvia Berra; Yoshinari Yasuda; Anna Henger; Felix Eichinger; Stefanie Gaiser; Holger Schmid; Maria P Rastaldi; Robert W Schrier; Detlef Schlöndorff; Clemens D Cohen
Journal:  J Am Soc Nephrol       Date:  2007-05-02       Impact factor: 10.121

8.  The peroxisome proliferator-activated receptor gamma agonist rosiglitazone ameliorates murine lupus by induction of adiponectin.

Authors:  Tamar Aprahamian; Ramon G Bonegio; Christophe Richez; Kei Yasuda; Lo-Ku Chiang; Kaori Sato; Kenneth Walsh; Ian R Rifkin
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

Review 9.  Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus.

Authors:  Benjamin F Chong; Chandra Mohan
Journal:  Expert Opin Ther Targets       Date:  2009-10       Impact factor: 6.902

10.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.

Authors:  B S Andrews; R A Eisenberg; A N Theofilopoulos; S Izui; C B Wilson; P J McConahey; E D Murphy; J B Roths; F J Dixon
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

View more
  82 in total

1.  Btk-specific inhibition blocks pathogenic plasma cell signatures and myeloid cell-associated damage in IFNα-driven lupus nephritis.

Authors:  Arna Katewa; Yugang Wang; Jason A Hackney; Tao Huang; Eric Suto; Nandhini Ramamoorthi; Cary D Austin; Meire Bremer; Jacob Zhi Chen; James J Crawford; Kevin S Currie; Peter Blomgren; Jason DeVoss; Julie A DiPaolo; Jonathan Hau; Adam Johnson; Justin Lesch; Laura E DeForge; Zhonghua Lin; Marya Liimatta; Joseph W Lubach; Sami McVay; Zora Modrusan; Allen Nguyen; Chungkee Poon; Jianyong Wang; Lichuan Liu; Wyne P Lee; Harvey Wong; Wendy B Young; Michael J Townsend; Karin Reif
Journal:  JCI Insight       Date:  2017-04-06

2.  Organoid single cell profiling identifies a transcriptional signature of glomerular disease.

Authors:  Jennifer L Harder; Rajasree Menon; Edgar A Otto; Jian Zhou; Sean Eddy; Noel L Wys; Christopher O'Connor; Jinghui Luo; Viji Nair; Cristina Cebrian; Jason R Spence; Markus Bitzer; Olga G Troyanskaya; Jeffrey B Hodgin; Roger C Wiggins; Benjamin S Freedman; Matthias Kretzler
Journal:  JCI Insight       Date:  2019-01-10

3.  Identification of stage-specific genes associated with lupus nephritis and response to remission induction in (NZB × NZW)F1 and NZM2410 mice.

Authors:  Ramalingam Bethunaickan; Celine C Berthier; Weijia Zhang; Ridvan Eksi; Hong-Dong Li; Yuanfang Guan; Matthias Kretzler; Anne Davidson
Journal:  Arthritis Rheumatol       Date:  2014-08       Impact factor: 10.995

Review 4.  Autoimmunity and organ damage in systemic lupus erythematosus.

Authors:  George C Tsokos
Journal:  Nat Immunol       Date:  2020-05-04       Impact factor: 25.606

Review 5.  Design and application of single-cell RNA sequencing to study kidney immune cells in lupus nephritis.

Authors:  Deepak A Rao; Arnon Arazi; David Wofsy; Betty Diamond
Journal:  Nat Rev Nephrol       Date:  2019-12-18       Impact factor: 28.314

Review 6.  Pro: 'The usefulness of biomarkers in glomerular diseases'. The problem: moving from syndrome to mechanism--individual patient variability in disease presentation, course and response to therapy.

Authors:  Laura H Mariani; Matthias Kretzler
Journal:  Nephrol Dial Transplant       Date:  2015-06       Impact factor: 5.992

7.  Integrative biology identifies shared transcriptional networks in CKD.

Authors:  Sebastian Martini; Viji Nair; Benjamin J Keller; Felix Eichinger; Jennifer J Hawkins; Ann Randolph; Carsten A Böger; Crystal A Gadegbeku; Caroline S Fox; Clemens D Cohen; Matthias Kretzler
Journal:  J Am Soc Nephrol       Date:  2014-06-12       Impact factor: 10.121

8.  Structure and function of renal macrophages and dendritic cells from lupus-prone mice.

Authors:  Ranjit Sahu; Ramalingam Bethunaickan; Satwinder Singh; Anne Davidson
Journal:  Arthritis Rheumatol       Date:  2014-06       Impact factor: 10.995

Review 9.  The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus Nephritis.

Authors:  Marcus R Clark; Kimberly Trotter; Anthony Chang
Journal:  Semin Nephrol       Date:  2015-09       Impact factor: 5.299

Review 10.  Renal Macrophages and Dendritic Cells in SLE Nephritis.

Authors:  Naomi I Maria; Anne Davidson
Journal:  Curr Rheumatol Rep       Date:  2017-11-09       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.